{"id":"W3083036202","doi":"10.1371/journal.pone.0237497","title":"Patient preferences and quality of life implications of ravulizumab (every 8 weeks) and eculizumab (every 2 weeks) for the treatment of paroxysmal nocturnal hemoglobinuria","year":2020,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":48,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Apellis Pharmaceuticals; Alexion Pharmaceuticals","keywords":"Eculizumab; Paroxysmal nocturnal hemoglobinuria; Medicine; Regimen; Dosing; Pediatrics; Internal medicine; Immunology; Antibody","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002585943,0.0001551352,0.0002719238,0.0001549512,0.0001807914,0.0004363681,0.0001197367,0.0003049919,0.002631163],"category_scores_gemma":[0.005328572,0.00007570517,0.0005831984,0.0001739805,0.0001756178,0.0003857879,0.0001914171,0.0004925054,0.0001932397],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003190013,"about_ca_system_score_gemma":0.0002543365,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005069564,"about_ca_topic_score_gemma":0.001062642,"domain_scores_codex":[0.998578,0.0009699879,0.0001117747,0.0000728631,0.0001690996,0.00009822228],"domain_scores_gemma":[0.9971119,0.0013564,0.000910227,0.00006992299,0.0001493108,0.0004022152],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.04165487,0.003108119,0.7244065,0.0004412338,0.001522077,0.0005693421,0.001424556,0.001554227,0.004951446,0.0003835433,0.003434658,0.2165496],"study_design_scores_gemma":[0.003717309,0.02621471,0.955058,0.0001134986,0.0005414909,0.002422354,0.001752882,0.004873058,0.001698596,0.0005569029,0.002963808,0.00008743333],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9982142,0.000554772,0.00009460315,0.0001859383,0.000008823547,0.00001641434,0.00008338847,0.000001614017,0.0008401778],"genre_scores_gemma":[0.9996161,0.00007807009,0.000100902,0.00008461991,0.00000547342,0.00001083546,0.00003769136,4.636032e-7,0.00006582329],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002631163,"threshold_uncertainty_score":0.01367599,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1067041951962957,"score_gpt":0.2765882071985561,"score_spread":0.1698840120022604,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}